Index RUT
P/E 46.92
EPS (ttm) 1.74
Insider Own 2.43%
Shs Outstand 57.86M
Perf Week 1.73%
Market Cap 4.76B
Forward P/E 22.49
EPS next Y 3.64
Insider Trans -4.76%
Shs Float 56.69M
Perf Month 13.72%
Income 101.95M
PEG 4.36
EPS next Q 0.88
Inst Own 100.24%
Short Float 3.98%
Perf Quarter 4.16%
Sales 1.28B
P/S 3.71
EPS this Y 10.69%
Inst Trans 1.98%
Short Ratio 5.68
Perf Half Y 17.50%
Book/sh 21.35
P/B 3.83
EPS next Y 9.20%
ROA 5.08%
Short Interest 2.26M
Perf Year -2.64%
Cash/sh 10.05
P/C 8.14
EPS next 5Y 10.77%
ROE 8.45%
52W Range 62.58 - 85.62
Perf YTD 7.73%
Dividend Est. -
P/FCF 35.58
EPS past 5Y 15.74%
ROI 4.85%
52W High -4.43%
Beta 0.90
Dividend TTM -
Quick Ratio 4.38
Sales past 5Y 7.42%
Gross Margin 42.94%
52W Low 30.76%
ATR (14) 1.60
Dividend Ex-Date -
Current Ratio 6.03
EPS Y/Y TTM 18.90%
Oper. Margin 10.88%
RSI (14) 71.38
Volatility 1.75% 2.21%
Employees 6950
Debt/Eq 0.70
Sales Y/Y TTM 9.62%
Profit Margin 7.96%
Recom 1.64
Target Price 91.60
Option/Short Yes / Yes
LT Debt/Eq 0.69
EPS Q/Q 35.53%
Payout 0.00%
Rel Volume 0.36
Prev Close 80.83
Sales Surprise 2.52%
EPS Surprise 7.78%
Sales Q/Q 9.07%
Earnings Apr 30 AMC
Avg Volume 397.27K
Price 81.83
SMA20 7.77%
SMA50 9.94%
SMA200 12.88%
Trades
Volume 79,429
Change 1.24%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-11-24 Initiated
CL King
Buy
$88
Feb-07-24 Initiated
BofA Securities
Neutral
$87
Dec-21-23 Upgrade
Canaccord Genuity
Hold → Buy
$100
Dec-20-22 Downgrade
Canaccord Genuity
Buy → Hold
$73 → $72
Jan-05-21 Upgrade
Needham
Hold → Buy
$65
Sep-28-20 Upgrade
Wells Fargo
Underweight → Equal Weight
$42
Feb-25-20 Downgrade
Barrington Research
Outperform → Mkt Perform
Feb-03-20 Upgrade
Raymond James
Mkt Perform → Outperform
$43
Dec-12-19 Downgrade
Wells Fargo
Market Perform → Underperform
$26
Sep-24-19 Initiated
Oppenheimer
Outperform
Sep-10-19 Downgrade
Raymond James
Outperform → Mkt Perform
Jul-26-19 Downgrade
Wells Fargo
Outperform → Market Perform
Jul-26-19 Downgrade
Needham
Buy → Hold
Oct-02-18 Reiterated
Needham
Buy
$67 → $73
Aug-07-18 Downgrade
BofA/Merrill
Buy → Underperform
Jul-24-18 Reiterated
Needham
Buy
$54 → $67
Jun-01-18 Reiterated
Needham
Buy
$54
May-18-18 Reiterated
SunTrust
Buy
$55 → $62
Apr-26-18 Reiterated
Needham
Buy
$53 → $54
Apr-20-18 Initiated
Needham
Buy
$53
Show Previous Ratings
Today 11:58AM
09:25AM
May-01-24 12:47PM
11:27AM
10:47AM
(Thomson Reuters StreetEvents)
09:15AM
Loading…
09:15AM
03:32AM
Apr-30-24 09:55PM
06:30PM
05:38PM
05:30PM
04:38PM
(Associated Press Finance)
04:05PM
Apr-23-24 10:01AM
Apr-10-24 09:33AM
11:30AM
Loading…
Mar-29-24 11:30AM
Mar-27-24 09:40AM
Mar-20-24 11:28AM
Mar-19-24 09:25AM
Mar-18-24 05:19PM
Mar-08-24 05:00PM
09:40AM
Mar-07-24 10:43AM
Mar-05-24 09:25AM
Mar-01-24 04:32AM
Feb-29-24 11:24AM
11:03AM
07:38AM
(Thomson Reuters StreetEvents)
Feb-28-24 07:00PM
06:15PM
05:21PM
Loading…
05:21PM
(Associated Press Finance)
04:05PM
04:05PM
Feb-23-24 09:15AM
Feb-21-24 10:00AM
Feb-19-24 08:38AM
Feb-15-24 09:25AM
Jan-31-24 12:10PM
09:50AM
Jan-30-24 09:55AM
Jan-24-24 01:01PM
Jan-23-24 07:19AM
Jan-16-24 04:05PM
Jan-08-24 09:00AM
Jan-03-24 04:05PM
Dec-27-23 05:11AM
Dec-18-23 04:05PM
Dec-15-23 09:50AM
Dec-11-23 10:25AM
Dec-06-23 09:00AM
Dec-04-23 04:05PM
Nov-15-23 07:28AM
Nov-01-23 09:55AM
Oct-31-23 11:40AM
Oct-30-23 01:37AM
Oct-27-23 12:20PM
11:16AM
10:51AM
(Thomson Reuters StreetEvents)
Oct-26-23 07:30PM
05:50PM
05:48PM
04:40PM
(Associated Press Finance)
04:05PM
07:52AM
Oct-25-23 10:21AM
Oct-12-23 11:55AM
Oct-10-23 11:40AM
09:25AM
Oct-05-23 11:05AM
09:25AM
Sep-19-23 09:00AM
Sep-07-23 07:22AM
Sep-06-23 09:25AM
Aug-30-23 12:46PM
Aug-15-23 01:20PM
Aug-10-23 07:58AM
Aug-08-23 06:50AM
Aug-03-23 09:25AM
Jul-26-23 12:07PM
Jul-25-23 08:00PM
05:45PM
04:43PM
04:05PM
Jul-21-23 06:51AM
Jul-13-23 11:56AM
Jul-11-23 11:40AM
Jul-07-23 07:20AM
Jul-06-23 01:11PM
Jul-03-23 07:51AM
Jun-26-23 10:50AM
Jun-22-23 11:40AM
Jun-21-23 08:00PM
11:35AM
Jun-19-23 10:24AM
Jun-14-23 11:51AM
11:22AM
Jun-13-23 01:59PM
11:22AM
Jun-09-23 01:39PM
Jun-08-23 04:01PM
Merit Medical Systems, Inc. engages in the manufacture and marketing of proprietary disposable medical devices. It operates through the Cardiovascular and Endoscopy segments. The Cardiovascular segment consists of peripheral intervention, cardiac intervention, interventional oncology and spine, and cardiovascular and critical care product groups. The Endoscopy segment integrates non-vascular stent technology with balloon dilators, inflation devices, guide wires, procedure kits, and other devices that are used by gastroenterologists, endoscopists, pulmonologists, and thoracic and general surgeons. The company was founded by Fred P. Lampropoulos, Darla Gill, Kent W. Stanger, and William Padilla in July 1987 and is headquartered in South Jordan, UT.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Parra Raul Jr. CFO AND TREASURER Mar 12 '24 Sale 73.95 6,480 479,182 12,007 Mar 13 06:36 PM Wright Joseph CHIEF COMMERCIAL OFFICER Mar 07 '24 Option Exercise 28.20 25,000 705,000 67,223 Mar 08 03:40 PM Wright Joseph CHIEF COMMERCIAL OFFICER Mar 07 '24 Sale 75.68 25,000 1,891,925 42,223 Mar 08 03:40 PM Peterson Neil CHIEF OPERATING OFFICER Mar 06 '24 Option Exercise 44.80 7,500 336,000 14,819 Mar 08 10:11 AM Gunderson Thomas James Director Mar 04 '24 Option Exercise 34.40 25,000 860,000 37,414 Mar 05 12:13 PM Gunderson Thomas James Director Mar 04 '24 Sale 76.03 18,157 1,380,513 19,257 Mar 05 12:13 PM Evans Stephen C. Director Mar 04 '24 Sale 76.35 1,000 76,348 7,226 Mar 05 10:13 AM Millner F. Ann Director Jan 22 '24 Option Exercise 34.40 20,000 688,000 49,960 Jan 24 10:49 AM Millner F. Ann Director Jan 22 '24 Sale 80.00 20,000 1,600,000 29,960 Jan 24 10:49 AM LAMPROPOULOS FRED P PRESIDENT AND CEO Aug 25 '23 Option Exercise 28.20 200,000 5,640,000 1,167,916 Aug 29 06:08 PM LAMPROPOULOS FRED P PRESIDENT AND CEO Aug 25 '23 Option Exercise 28.20 6,000 169,200 12,888 Aug 29 06:08 PM Peterson Neil CHIEF OPERATING OFFICER Aug 22 '23 Option Exercise 28.20 8,000 225,600 8,000 Aug 23 11:32 AM Peterson Neil CHIEF OPERATING OFFICER Aug 22 '23 Sale 67.91 8,000 543,288 0 Aug 23 11:32 AM ANDERSON A SCOTT Director Aug 09 '23 Option Exercise 50.50 25,000 1,262,500 71,397 Aug 11 05:30 PM ANDERSON A SCOTT Director Aug 09 '23 Sale 69.40 22,180 1,539,292 49,217 Aug 11 05:30 PM
Index RUT
P/E 40.26
EPS (ttm) 1.69
Insider Own 5.15%
Shs Outstand 49.87M
Perf Week -2.47%
Market Cap 3.42B
Forward P/E 29.00
EPS next Y 2.35
Insider Trans -4.38%
Shs Float 47.60M
Perf Month 3.50%
Income 90.22M
PEG 4.58
EPS next Q 0.50
Inst Own 90.46%
Short Float 2.25%
Perf Quarter 3.87%
Sales 895.25M
P/S 3.82
EPS this Y 4.07%
Inst Trans 1.97%
Short Ratio 3.93
Perf Half Y 20.30%
Book/sh 14.53
P/B 4.68
EPS next Y 8.95%
ROA 6.34%
Short Interest 1.07M
Perf Year 40.42%
Cash/sh 14.90
P/C 4.57
EPS next 5Y 8.80%
ROE 13.33%
52W Range 48.01 - 77.29
Perf YTD 5.35%
Dividend Est. -
P/FCF 18.81
EPS past 5Y 28.66%
ROI 7.26%
52W High -11.92%
Beta 0.89
Dividend TTM -
Quick Ratio 5.03
Sales past 5Y 16.16%
Gross Margin 60.17%
52W Low 41.79%
ATR (14) 1.74
Dividend Ex-Date -
Current Ratio 5.51
EPS Y/Y TTM 45.83%
Oper. Margin 8.57%
RSI (14) 49.98
Volatility 3.19% 2.48%
Employees 1989
Debt/Eq 0.72
Sales Y/Y TTM 5.72%
Profit Margin 10.08%
Recom 1.89
Target Price 80.90
Option/Short Yes / Yes
LT Debt/Eq 0.71
EPS Q/Q 58.97%
Payout 0.00%
Rel Volume 0.43
Prev Close 68.01
Sales Surprise 1.79%
EPS Surprise 2.48%
Sales Q/Q 6.47%
Earnings May 09 AMC
Avg Volume 272.57K
Price 68.07
SMA20 2.02%
SMA50 -2.66%
SMA200 9.32%
Trades
Volume 65,007
Change 0.10%
Date
Action
Analyst
Rating Change
Price Target Change
Jul-05-23 Resumed
JP Morgan
Neutral
$55
Apr-20-22 Initiated
BofA Securities
Buy
$75
Jul-12-21 Initiated
Barclays
Equal Weight
$100
Apr-08-21 Upgrade
Imperial Capital
In-line → Outperform
$105
Apr-06-21 Initiated
JP Morgan
Neutral
$100
Sep-30-20 Upgrade
ROTH Capital
Neutral → Buy
$65
Aug-03-20 Downgrade
William Blair
Outperform → Mkt Perform
Feb-27-20 Reiterated
Imperial Capital
Outperform
$57 → $59
Jan-27-20 Reiterated
Imperial Capital
In-line
$51 → $57
Nov-07-19 Reiterated
Imperial Capital
In-line
$58 → $51
Oct-21-19 Upgrade
First Analysis Sec
Outperform → Strong Buy
Aug-13-19 Reiterated
Imperial Capital
In-line
$64 → $58
May-13-19 Reiterated
Imperial Capital
In-line
$61 → $64
May-10-19 Reiterated
Maxim Group
Buy
$74 → $79
May-10-19 Downgrade
First Analysis Sec
Strong Buy → Outperform
$75
May-03-19 Reiterated
BofA/Merrill
Buy
$67 → $78
Apr-29-19 Downgrade
ROTH Capital
Buy → Neutral
Mar-04-19 Downgrade
Imperial Capital
Outperform → In-line
$58 → $61
Mar-01-19 Reiterated
Maxim Group
Buy
$69 → $74
Nov-13-18 Upgrade
Imperial Capital
In-line → Outperform
$60 → $58
Show Previous Ratings
May-11-24 03:04PM
May-10-24 01:09PM
(Thomson Reuters StreetEvents)
12:49PM
10:24AM
May-09-24 10:54PM
04:47PM
Loading…
04:47PM
(Associated Press Finance)
04:09PM
04:05PM
May-08-24 06:15AM
03:07AM
May-03-24 10:00AM
Apr-19-24 04:20AM
Apr-16-24 08:00AM
06:15AM
Apr-10-24 04:52AM
06:15AM
Loading…
Apr-09-24 06:15AM
Apr-05-24 10:00AM
Mar-28-24 04:18PM
Mar-27-24 10:00AM
Mar-11-24 09:57AM
Mar-06-24 09:00AM
Mar-01-24 12:38AM
Feb-26-24 06:15AM
Feb-23-24 04:30PM
(Investor's Business Daily)
11:54AM
06:31AM
(Thomson Reuters StreetEvents)
Feb-22-24 05:40PM
04:37PM
(Associated Press Finance)
04:36PM
04:16PM
04:05PM
Loading…
04:05PM
Feb-21-24 02:02AM
Feb-14-24 06:15AM
Feb-01-24 12:03PM
Jan-24-24 06:15AM
Jan-23-24 12:10PM
Dec-29-23 04:04PM
(Investor's Business Daily)
Dec-28-23 04:05PM
Dec-27-23 08:00AM
Dec-21-23 07:31PM
Dec-19-23 08:00AM
Dec-15-23 09:40AM
Nov-28-23 09:40AM
Nov-27-23 12:00PM
Nov-10-23 10:55AM
Nov-09-23 05:32PM
(Associated Press Finance)
04:18PM
04:05PM
Nov-08-23 06:15AM
02:02AM
Nov-02-23 10:00AM
Oct-31-23 04:12AM
Oct-18-23 06:15AM
Oct-17-23 05:55PM
Sep-26-23 09:00AM
08:28AM
Sep-12-23 07:00AM
Sep-07-23 06:34PM
Sep-05-23 09:00AM
Aug-31-23 09:00AM
Aug-10-23 04:05PM
07:55AM
(Thomson Reuters StreetEvents)
Aug-09-23 06:30PM
05:21PM
04:05PM
Aug-08-23 06:30AM
Aug-04-23 08:51AM
Jul-26-23 06:30AM
Jul-25-23 06:30AM
Jul-19-23 06:15AM
Jul-18-23 06:35AM
Jul-07-23 11:40AM
Jul-04-23 11:42AM
Jun-29-23 06:45AM
Jun-21-23 08:00PM
Jun-07-23 07:50PM
Jun-05-23 09:00AM
Jun-04-23 08:36AM
Jun-01-23 10:20AM
May-22-23 06:45AM
May-17-23 09:00AM
May-13-23 02:11PM
May-11-23 09:22AM
(Thomson Reuters StreetEvents)
May-10-23 06:25PM
05:23PM
04:05PM
May-09-23 04:30PM
May-08-23 07:58AM
May-05-23 11:40AM
Apr-26-23 08:00PM
Apr-25-23 04:30PM
Apr-20-23 06:15AM
Apr-12-23 11:18AM
Apr-06-23 07:20AM
Mar-23-23 06:15AM
Mar-14-23 10:34AM
Feb-27-23 07:17AM
Feb-25-23 07:07AM
Feb-24-23 09:19AM
(Thomson Reuters StreetEvents)
Feb-23-23 06:50PM
Alarm.com Holdings, Inc. engages in the provision of wireless and web-enabled security system technology. The firm offers security, video monitoring, and energy management solutions. It operates through the Alarm.com and Other segments. The Alarm.com segment represents cloud-based platform for the connected home and related connected home solutions. The Other segment focuses on the research and development of home and commercial automation, as well as energy management products and services. The company was founded by Jean-Paul Martin and Alison J. Slavin in 2000 and is headquartered in Tysons, VA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Trundle Stephen Chief Executive Officer Apr 02 '24 Sale 70.00 3,217 225,190 234,449 Apr 03 05:19 PM Kerzner Daniel See Remarks Apr 02 '24 Sale 70.00 2,820 197,400 54,531 Apr 03 05:13 PM Valenzuela Steve Chief Financial Officer Apr 02 '24 Sale 70.00 1,716 120,120 35,784 Apr 03 05:22 PM Ramos Daniel See Remarks Apr 02 '24 Sale 70.00 1,418 99,260 38,282 Apr 03 05:16 PM BEDELL JEFFREY A See Remarks Apr 02 '24 Sale 70.00 1,418 99,260 479,252 Apr 03 05:11 PM NEVIN DARIUS G Director Mar 15 '24 Sale 73.55 2,593 190,715 19,561 Mar 15 05:10 PM Valenzuela Steve Chief Financial Officer Mar 07 '24 Option Exercise 53.39 832 44,423 38,332 Mar 08 05:49 PM Valenzuela Steve Chief Financial Officer Mar 07 '24 Sale 74.58 832 62,051 37,500 Mar 08 05:49 PM Valenzuela Steve Chief Financial Officer Feb 29 '24 Option Exercise 61.45 7,083 435,239 44,583 Feb 29 08:05 PM Valenzuela Steve Chief Financial Officer Feb 29 '24 Sale 75.34 7,083 533,633 37,500 Feb 29 08:05 PM Valenzuela Steve Chief Financial Officer Feb 27 '24 Option Exercise 47.60 9,583 456,154 47,083 Feb 29 08:05 PM Ramos Daniel See Remarks Feb 27 '24 Option Exercise 53.96 8,250 445,165 47,950 Feb 27 07:05 PM Valenzuela Steve Chief Financial Officer Feb 27 '24 Sale 73.89 9,583 708,088 37,500 Feb 29 08:05 PM Ramos Daniel See Remarks Feb 27 '24 Sale 74.44 8,250 614,130 39,700 Feb 27 07:05 PM Evans Stephen C. Director Feb 27 '24 Sale 74.12 1,000 74,120 6,088 Feb 27 07:04 PM Trundle Stephen Chief Executive Officer Feb 23 '24 Sale 73.80 50,000 3,689,908 1,289,343 Feb 27 07:04 PM Kerzner Daniel See Remarks Feb 15 '24 Option Exercise 11.55 10,000 115,500 85,784 Feb 16 05:01 PM Kerzner Daniel See Remarks Feb 15 '24 Sale 69.98 28,433 1,989,641 57,351 Feb 16 05:01 PM Valenzuela Steve Chief Financial Officer Aug 15 '23 Sale 57.16 2,693 153,932 37,500 Aug 16 04:33 PM Ramos Daniel See Remarks Aug 15 '23 Sale 57.73 795 45,895 39,700 Aug 16 04:32 PM Ramos Daniel See Remarks Aug 14 '23 Option Exercise 37.87 3,834 145,195 49,230 Aug 16 04:32 PM Ramos Daniel See Remarks Aug 14 '23 Sale 59.78 8,735 522,178 40,495 Aug 16 04:32 PM Valenzuela Steve Chief Financial Officer Aug 14 '23 Sale 58.48 5,000 292,400 40,193 Aug 16 04:33 PM WU Simone Director Jun 07 '23 Sale 52.00 868 45,136 4,982 Jun 09 04:36 PM Ramos Daniel See Remarks May 23 '23 Sale 51.45 2,400 123,480 45,396 May 24 07:06 PM Trundle Stephen Chief Executive Officer May 16 '23 Sale 48.82 4,694 229,161 217,666 May 18 04:38 PM BEDELL JEFFREY A See Remarks May 16 '23 Sale 48.82 3,051 148,950 463,170 May 18 04:36 PM Kerzner Daniel See Remarks May 16 '23 Sale 48.82 2,420 118,144 58,284 May 18 04:37 PM Ramos Daniel See Remarks May 16 '23 Sale 48.82 1,660 81,041 33,796 May 18 04:37 PM Valenzuela Steve Chief Financial Officer May 16 '23 Sale 48.82 1,566 76,452 32,693 May 18 04:40 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite